Source study found

Story checked

ADHD linked to higher mortality but medication may help (opens in a new tab)

medicalxpress.com · 2026-10-19

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

2 supported
2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail

The story

ADHD linked to higher mortality but medication may help

medicalxpress.com · 2026-10-19

The story’s checkable claims.

Read the original story

NewsLink checks it

Mixed

Every claim we could check holds up. Two of four claims match the study. This overall rating is based only on the claims we could check. Two claims the study doesn't address.

2 supported
2 not covered

Open claim evidence

The source study

Mortality Among People With Attention-Deficit/Hyperactivity Disorder

JAMA Network Open · 2026

Open source record

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

Reading mode

Scan verdicts. Open evidence only when needed.

Browse by verdict

4 claims in this story

Showing all 4 claimsChoose a verdict to focus the list.

Claim 1 of 4Not coveredThe study, published in JAMA Network Open, was a systematic review and meta-analysis of 19 studies involving close to 16 million participants on three continents.View evidenceHide evidence

As stated19 studies; close to 16 million participants

Why this verdict

The abstract-level profile supports that the paper was a systematic review and random-effects meta-analysis including 19 studies and 15,920,970 participants, which matches 'close to 16 million.' However, the supplied abstract profile only describes the evidence as international and does not verify the 'three continents' detail; journal publication details are also not explicitly established in the unit evidence beyond the supplied document context.

Study evidence

ADHD was associated with increased all-cause mortality in pooled analysis of included studies.HR 1.71 (95% CI, 1.31–2.24; P < .001)

“A comprehensive search of PubMed, Web of Science, PsycINFO, EMBASE, MEDLINE, and CINAHL was conducted from database inception to July 8, 2025.”

Claim 2 of 4Not coveredAmong people with ADHD, those who took ADHD medication appeared to have a 25% lower mortality risk, but the article says this was based on only three of the 19 included studies.View evidenceHide evidence

As stated25% lower mortality risk

Why this verdict

The abstract-level profile supports the associational, hedged statement that ADHD medication use among people with ADHD was associated with lower all-cause mortality, HR 0.75, equivalent to about 25% lower mortality. But the supplied profile does not verify the story's additional claim that this medication finding was based on only three of the 19 included studies.

Study evidence

Among people with ADHD, pooled estimates from included studies indicate that ADHD medication use was associated with reduced all-cause mortality.HR 0.75 (95% CI 0.64–0.87)

“Clarifying... the potential association between medication and mortality is essential”

Claim 3 of 4SupportedIn the meta-analysis of observational studies, ADHD was linked to higher rates of suicide deaths, injury deaths, and a moderate increase in natural-cause mortality.View evidenceHide evidence

As stated70% higher all-cause death rate; 90% higher suicide death rate; 55% higher injury death rate; 27% higher natural-cause death rate

Why this verdict

The story frames the findings as associations from observational/meta-analytic evidence, not causal effects. The profile reports ADHD-associated higher all-cause mortality HR 1.71, suicide mortality HR 1.89, injury mortality HR 1.55, and natural-cause mortality HR 1.27, corresponding closely to the stated 70%, 90%, 55%, and 27% higher mortality figures.

Study evidence

ADHD was associated with increased all-cause mortality in pooled analysis of included studies.HR 1.71 (95% CI, 1.31–2.24; P < .001)

“A comprehensive search of PubMed, Web of Science, PsycINFO, EMBASE, MEDLINE, and CINAHL was conducted from database inception to July 8, 2025.”

Study evidence

Pooled analysis found higher suicide mortality among individuals with ADHD compared with those without ADHD.HR 1.89 (95% CI, 1.21–2.95; P = .005)

“The primary outcomes were all-cause mortality and cause-specific mortality (suicide, unintentional or intentional injury, and natural causes), measured using HRs with 95% CIs.”

Claim 4 of 4SupportedThe authors caution that, because all included studies were observational, it is not possible to infer causality.View evidenceHide evidence

Why this verdict

The profile describes the included evidence as observational and notes residual confounding and the need for improved control of confounding. The story's caveat that causality cannot be inferred is consistent with those limitations and does not overstate the paper.

Study evidence

ADHD was associated with increased all-cause mortality in pooled analysis of included studies.HR 1.71 (95% CI, 1.31–2.24; P < .001)

“A comprehensive search of PubMed, Web of Science, PsycINFO, EMBASE, MEDLINE, and CINAHL was conducted from database inception to July 8, 2025.”

Study evidence

Pooled analysis found higher suicide mortality among individuals with ADHD compared with those without ADHD.HR 1.89 (95% CI, 1.21–2.95; P = .005)

“The primary outcomes were all-cause mortality and cause-specific mortality (suicide, unintentional or intentional injury, and natural causes), measured using HRs with 95% CIs.”

Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

Included studies used heterogeneous ADHD definitions, including diagnostic criteria, self-identification, trait measures, or polygenic risk scores, which may affect pooled estimates.
This limitation is present in the paper profile but is not mentioned in the story caveats. It is potentially interpretation-changing because different exposure definitions can affect comparability across pooled mortality estimates.
From Systematic review and random-effects meta-analysis of hazard ratios
Study quality assessment was described as being performed by one reviewer, which may limit reliability of appraisal.
The supplied profile notes this methods limitation, but the story does not mention it.
From Systematic review and random-effects meta-analysis of hazard ratios; Systematic review and random-effects meta-analysis

6 things the story did carry across

The paper is a systematic review and random-effects meta-analysis of mortality outcomes in ADHD, including 19 studies and 15,920,970 participants.
ADHD was associated with increased all-cause mortality, with pooled HR 1.71 (95% CI, 1.31–2.24).
ADHD was associated with higher cause-specific mortality for suicide, injury, and natural causes, with HRs 1.89, 1.55, and 1.27 respectively.
ADHD medication use among people with ADHD was associated with reduced all-cause mortality, HR 0.75 (95% CI, 0.64–0.87).
Substantial heterogeneity was observed across included studies, limiting precision and comparability of pooled estimates.
The evidence is observational and subject to residual confounding; causal inference is not warranted from these pooled associations.

Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataQuantify the association between ADHD and all-cause mortality using international evidence.Systematic review and random-effects meta-analysisExpand

In plain English

Systematic review and random-effects meta-analysis pooling hazard ratios (HRs) from 19 studies (15,920,970 participants) found that ADHD was associated with increased all-cause mortality (HR 1.71, 95% CI 1.31–2.24). ADHD medication use was associated with reduced all-cause mortality (HR 0.75, 95% CI 0.64–0.87). Substantial heterogeneity was observed across studies.

Key findings

ADHD was associated with increased all-cause mortality in pooled analysis of included studies.HR 1.71 (95% CI, 1.31–2.24; P < .001)
Among people with ADHD, use of ADHD medication was associated with reduced all-cause mortality.HR 0.75 (95% CI, 0.64–0.87; P < .001)

“A comprehensive search of PubMed, Web of Science, PsycINFO, EMBASE, MEDLINE, and CINAHL was conducted from database inception to July 8, 2025.”

What this piece can’t prove

Substantial heterogeneity across included studies.
Need for standardized methods and improved control of confounding factors to better characterize mortality risk.

2secondary dataQuantify the association between ADHD and cause-specific mortality (suicide, injury, natural causes) using international evidence.Systematic review and random-effects meta-analysis of hazard ratiosExpand

In plain English

Systematic review and random-effects meta-analysis pooling hazard ratios (HRs) for cause-specific mortality among people with ADHD (suicide, unintentional/intentional injury, and natural-cause deaths) using international studies identified through a comprehensive search to July 8, 2025. Pooled estimates indicate increased risk for each cause-specific category.

Key findings

Pooled analysis found higher suicide mortality among individuals with ADHD compared with those without ADHD.HR 1.89 (95% CI, 1.21–2.95; P = .005)
Pooled analysis found increased mortality due to unintentional or intentional injury in individuals with ADHD.HR 1.55 (95% CI, 1.22–2.00; P < .001)

“The primary outcomes were all-cause mortality and cause-specific mortality (suicide, unintentional or intentional injury, and natural causes), measured using HRs with 95% CIs.”

What this piece can’t prove

Substantial heterogeneity observed across studies limits the precision and comparability of pooled cause-specific estimates.
Included studies used heterogeneous definitions of ADHD (diagnostic criteria, self-identification, trait measures, polygenic risk scores), which may affect pooled estimates.
Study quality assessment was performed by a single reviewer (as reported).
Authors note the need for standardized methods and improved control of confounding factors in future research.

3secondary dataAssess whether ADHD medication use (among people with ADHD) is associated with different all-cause mortality risk.Systematic review and random-effects meta-analysis (within-ADHD medication exposure contrast)Expand

In plain English

Systematic review and random-effects meta-analysis examined the association between ADHD medication use (vs nonuse) and all-cause mortality among people with ADHD; pooled estimate from included studies indicates lower all-cause mortality associated with medication use (HR 0.75, 95% CI 0.64–0.87), with substantial between-study heterogeneity reported.

Key findings

Among people with ADHD, pooled estimates from included studies indicate that ADHD medication use was associated with reduced all-cause mortality.HR 0.75 (95% CI 0.64–0.87)

“Clarifying... the potential association between medication and mortality is essential”

What this piece can’t prove

Substantial between-study heterogeneity in the pooled medication–mortality estimates.
Included evidence derived from observational studies, which may be subject to residual confounding.
Abstract does not report standardized exposure definitions for medication use across studies; heterogeneity in exposure measurement may affect estimates.
Study quality assessment was described as performed by one reviewer (potential limitation in quality appraisal reliability).

Finally, the search trail

Method layer